关于这个播客 🔗

主持人:
更新频率:
every 26 days
平均音频长度:
30 minutes
嘉宾访谈
英语
美国
15 集
自从 2025年8月20日
episodic

最新一集 🔗

The way life sciences companies have commercialised products for years is being challenged from every direction. Changing customer expectations, growing market complexity, new technologies, and evolving healthcare ecosystems are all raising the same question: Is improving the current model enoug...

搜索以前的节目

搜索Improzone以前的节目。

以前的节目

AI is changing the way life sciences organisations think about technology, talent, and transformation. But as the pace of innovation accelerates, one question is becoming harder to ignore: What should companies build themselves, what should they partner for, and what does the future workforce nee...
Season 2 Miniseries Episode 4.3 is officially live. New Improzone Podcast Episode In this episode, Jane Urban sits down with Jason Harlander (Executive Director, Technology Management, Improzo) to explore what the future of CRM in life sciences could look like and why the next evolution of CRM i...
Season 2 Miniseries Episode 4.2 is officially live.New Improzone Podcast EpisodeIn this episode, Jane Urban sits down with Jason Harlander (Executive Director, Technology Management, Improzo) to unpack the present-day realities of CRM transformation, where life sciences, data, and technology inte...
Season 2 Episode 4.1 is officially live. New Improzone Podcast Episode In this episode, Jane Urban sits down with Jason Harlander (Executive Director, Technology Management, Improzo) to explore the origins of CRM in life sciences and how early decisions continue to shape the industry today. Key...
New Improzone Podcast Episode Jane Urban sits down with Navdeep Singh (AWS Customer Success Leader) to explore Perception vs. Perspective: Rethinking AI Adoption in Biopharma, a conversation that goes beyond the hype to examine how AI is actually being adopted across life sciences organizations t...
New Improzone Podcast Episode Jane Urban sits down with Stephen Gatchell (Ortecha) to explore how MDM and AI are evolving together — and why the “golden record” mindset no longer works at scale.Key takeaways:• MDM is shifting from rigid systems of truth to context-driven data philosophies• AI-ena...
Most biotech companies are stuck in "pilot purgatory" with Generative AI. But moving from a fun experiment to a scalable, enterprise-grade solution requires more than just a software license, it demands a fundamental shift in how IT partners with Legal, QA, and Regulatory teams. In the Season 2 p...
We are LIVE with the finale of our mini-series! In Episode 4.4 - The AI Adoption Arc, we shift the focus outward to exploring Externally Facing AI Tools.While internal efficiencies are critical, the true competitive advantage in Life Sciences lies in how AI reshapes your customer touchpoints. Fro...
In the latest episode of The Improzone Mini-Series 4.3, we explore the critical shift from legal compliance to technical verification. Key Insight: Treat your third-party AI like an "over-eager intern"—talented, capable, but lacking the judgment to represent your brand without supervisi...
免责声明: 本页面嵌入的播客和封面图片来自 Improzo,归其所有者所有,与 Listen Notes, Inc. 无关联,也未获得 Listen Notes, Inc. 背书。